 Factors pulmonary deposition aerosolized pentamidine patients human immunodeficiency virus infection aerosolized pentamidine AP prophylaxis clinical trials treatment pneumocystis pneumonia PCP factors important deposition AP radioaerosol techniques deposition patients AP prophylaxis treatment PCP patients total regional deposition pentamidine pattern pulmonary function PFT regional ventilation type nebulizer Bronchoalveolar lavage BAL inhalation relationship pentamidine levels BAL fluid aerosol deposition nebulizers Marquest Respirgard II Cadema AeroTech II laboratory aerosol consist water droplets dissolved pentamidine technetium bound Analysis particles inhalation cascade impaction close relationship radioactivity droplets concentration pentamidine HPLC Deposition inhaled exhaled particles absolute filters radioactivity technique determination deposition fraction DF fraction amount information factors patient filter measurements pentamidine deposition gamma camera camera measurement possible patient thoracic attenuation radioactivity quantitative perfusion scan mg pentamidine techniques Regional lung volume ventilation equilibrium scan washout Pentamidine deposition patients BAL levels pentamidine deposition DF SEM measured lung parameter pattern PFT Regional deposition regional ventilation major factor pentamidine deposition aerosol delivery mg mg nebulizer important determinant aerosol delivery AeroTech delivering times drug Respirgard observations important treatment failure cost therapy